Stay informed with the latest litigation news. Explore now

IP Verse

Patent opposition analysis in digestive drugs industry

In the competitive field of digestive drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in digestive drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the digestive drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Sep 4, 2025
CompanyTotal Oppositions
TEVA PHARMACEUTICALS51
SANDOZ37
GENERICS UK35
NUTRICIA24
STADA ARZNEIMITTEL24
HOFFMANN EITLE15
AERA13
FRESENIUS KABI DEUTSCHLAND13
NESTLE12
ALFRED E TIEFENBACHER12

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Sep 4, 2025
CompanyTotal Oppositions
NOVARTIS33
REGENERON PHARMACEUTICALS33
SANOFI BIOTECHNOLOGY31
NUTRICIA25
BOEHRINGER INGELHEIM23
COUGAR BIOTECHNOLOGY22
JANSSEN ONCOLOGY22
ASTELLAS PHARMA21
GLAXO GROUP18
NESTLE18

Top active law firms filing patent oppositions

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Sep 4, 2025
CompanyTotal Oppositions Filed
ELKINGTON AND FIFE57
HAMM & WITTKOPP43
TER MEER STEINMEISTER & PARTNER41
D YOUNG39
MAIWALD24
KRAUS & LEDERER PARTGMBB22
NEDERLANDSCH OCTROOIBUREAU22
HOFFMANN EITLE20
CARPMAELS & RANSFORD14
FRESENIUS KABI DEUTSCHLAND13

Latest patents opposed in the digestive drugs industry

Patent challenges are becoming increasingly common in the digestive drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the digestive drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the digestive drugs industry

EP3979834
Composition Containing A Yeast For Preventing Simple And/Or Recurring CystitisLESAFFRE ET COMPAGNIEJul 23, 2025BIOCODEX
EP3305321
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 16, 2025J A KEMP
EP3305321
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA HAKKO KIRINJul 15, 2025ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB
EP4062916
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025BRAND MURRAY FULLER
EP4252857
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
EP3000874
Sex Sorted Sperm Demonstrating A Dose Response And Methods Of Producing Sex Sorted Sperm Demonstrating A Dose ResponseINGURANJun 18, 2025ABS
EP3854403
Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
EP3487881
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3487881
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 20, 2025NEUEFEIND
EP3801459
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025SYNTHON

Top patents facing oppositions in digestive drugs industry

To stay ahead in the competitive digestive drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the digestive drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2478907
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
EP3725778
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
EP2228064
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
EP2400950
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
EP2981271
Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM8
EP2350096
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
EP3703818
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
EP3487881
Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTIS7
EP3515465
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
EP3889181
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7